EditorialKommentar
Editorial Comment: Duration of Axillary Lymphadenopathy After COVID-19 Vaccine Booster Administration
American Journal of Roentgenology · 2023
DOI: 10.2214/ajr.23.29309 ↗Kurz gefasst
Editorial in der Zeitschrift American Journal of Roentgenology, 2023. Verfasst von Lisa A Mullen. Beteiligte Einrichtung: Johns Hopkins Medicine, Baltimore, MD, lmullen1@jhmi.edu. Hauptthemen laut MEDLINE: Lymphadenopathy, COVID-19. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
LymphadenopathyCOVID-19UltrasonographyImmunization, SecondaryCOVID-19 VaccinesHumansFollow-Up Studies
Substanzen
COVID-19 Vaccines
Autor:innen und Institutionen
- Johns Hopkins Medicine, Baltimore, MD, lmullen1@jhmi.edu.
Zitieren
APA
Mullen, L. A. (2023). Editorial Comment: Duration of Axillary Lymphadenopathy After COVID-19 Vaccine Booster Administration. American Journal of Roentgenology. https://doi.org/10.2214/ajr.23.29309
Vancouver
Mullen LA. Editorial Comment: Duration of Axillary Lymphadenopathy After COVID-19 Vaccine Booster Administration. American Journal of Roentgenology. 2023. doi:10.2214/ajr.23.29309
BibTeX
@article{Mullen2023,
author = {Mullen, Lisa A},
title = {Editorial Comment: Duration of Axillary Lymphadenopathy After COVID-19 Vaccine Booster Administration},
journal = {American Journal of Roentgenology},
year = {2023},
doi = {10.2214/ajr.23.29309}
}
EUVIMED